Identifying regulators for EAG1 channels with a novel electrophysiology and tryptophan fluorescence based screen

PLoS ONE

Volumn 5, Issue 9, 2010, Pages 1-11

  Brelidze, Tinatin I ^a   Carlson, Anne E ^a   Davies, Douglas R ^b   Stewart, Lance J ^b   Zagotta, William N ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b Emerald BioStructures   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZOFURAN DERIVATIVE; FLAVONOID; INDOLE; LUTEOLIN; MYRICETIN; POTASSIUM CHANNEL HERG; TRYPTOPHAN; LIGAND;

ARTICLE; CARBOXY TERMINAL SEQUENCE; CHANNEL GATING; CHEMICAL ANALYSIS; CHEMICAL STRUCTURE; ELECTROPHYSIOLOGY; NONHUMAN; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PURIFICATION; SCREENING; ANIMAL; CHEMISTRY; DRUG SCREENING; EVALUATION; GENETICS; METABOLISM; METHODOLOGY; MOUSE; PROTEIN TERTIARY STRUCTURE;

ANIMALS; DRUG EVALUATION, PRECLINICAL; ELECTROPHYSIOLOGY; ETHER-A-GO-GO POTASSIUM CHANNELS; LIGANDS; MICE; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; TRYPTOPHAN;

EID: 77958542469     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0012523     Document Type: Article

References (42)

1. Bruford EA, Lush MJ, Wright MW, Sneddon TP, Povey S, et al. (2008) The HGNC Database in 2008: a resource for the human genome. Nucleic Acids Res 36: D445-448.
2. Warmke JW, Ganetzky B (1994) A family of potassium channel genes related to eag in Drosophila and mammals. Proc Natl Acad Sci U S A 91: 3438-3442.
3. Ludwig J, Terlau H, Wunder F, Bruggemann A, Pardo LA, et al. (1994) Functional expression of a rat homologue of the voltage gated either a go-go potassium channel reveals differences in selectivity and activation kinetics between the Drosophila channel and its mammalian counterpart. Embo J 13: 4451-4458.
4. Camacho J (2006) Ether a go-go potassium channels and cancer. Cancer Lett 233: 1-9.
5. Farias LM, Ocana DB, Diaz L, Larrea F, Avila-Chavez E, et al. (2004) Ether a go-go potassium channels as human cervical cancer markers. Cancer Res 64: 6996-7001.
6. Meyer R, Schonherr R, Gavrilova-Ruch O, Wohlrab W, Heinemann SH (1999) Identification of ether a go-go and calcium-activated potassium channels in human melanoma cells. J Membr Biol 171: 107-115.
7. Ousingsawat J, Spitzner M, Puntheeranurak S, Terracciano L, Tornillo L, et al. (2007) Expression of voltage-gated potassium channels in human and mouse colonic carcinoma. Clin Cancer Res 13: 824-831.
8. Pardo LA, del Camino D, Sanchez A, Alves F, Bruggemann A, et al. (1999) Oncogenic potential of EAG K(+) channels. EMBO J 18: 5540-5547.
9. Gavrilova-Ruch O, Schonherr K, Gessner G, Schonherr R, Klapperstuck T, et al. (2002) Effects of imipramine on ion channels and proliferation of IGR1 melanoma cells. J Membr Biol 188: 137-149.
10. Gomez-Varela D, Zwick-Wallasch E, Knotgen H, Sanchez A, Hettmann T, et al. (2007) Monoclonal antibody blockade of the human Eag1 potassium channel function exerts antitumor activity. Cancer Res 67: 7343-7349.
11. Mello de Queiroz F, Suarez-Kurtz G, Stuhmer W, Pardo LA (2006) Ether a go-go potassium channel expression in soft tissue sarcoma patients. Mol Cancer 5: 42.
12. Weber C, Mello de Queiroz F, Downie BR, Suckow A, Stuhmer W, et al. (2006) Silencing the activity and proliferative properties of the human EagI Potassium Channel by RNA Interference. J Biol Chem 281: 13030-13037.
13. Morais Cabral JH, Lee A, Cohen SL, Chait BT, Li M, et al. (1998) Crystal structure and functional analysis of the HERG potassium channel N terminus: a eukaryotic PAS domain. Cell 95: 649-655.
14. Taylor BL, Zhulin IB (1999) PAS domains: internal sensors of oxygen, redox potential, and light. Microbiol Mol Biol Rev 63: 479-506.
15. Guy HR, Durell SR, Warmke J, Drysdale R, Ganetzky B (1991) Similarities in amino acid sequences of Drosophila eag and cyclic nucleotide-gated channels. Science 254: 730.
16. Brelidze TI, Carlson AE, Zagotta WN (2009) Absence of direct cyclic nucleotide modulation of mEAG1 and hERG1 channels revealed with fluorescence and electrophysiological methods. J Biol Chem 284: 27989-27997.
17. + channels in Drosophila and mammals. Ann N Y Acad Sci 868: 356-369.
18. Davies DR, Mamat B, Magnusson OT, Christensen J, Haraldsson MH, et al. (2009) Discovery of leukotriene A4 hydrolase inhibitors using metabolomics biased fragment crystallography. J Med Chem 52: 4694-4715.
19. Lakowicz JR (2006) Principles Of Fluorescence Spectroscopy. New York, NY: Springer. pp 56 and 551.
20. Colquhoun D (1998) Binding, gating, affinity and efficacy: the interpretation of structure-activity relationships for agonists and of the effects of mutating receptors. Br J Pharmacol 125: 924-947.
21. de Jong LA, Uges DR, Franke JP, Bischoff R (2005) Receptor-ligand binding assays: technologies and applications. J Chromatogr B Analyt Technol Biomed Life Sci 829: 1-25.
22. Fan F, Wood KV (2007) Bioluminescent assays for high-throughput screening. Assay Drug Dev Technol 5: 127-136.
23. Fox S, Farr-Jones S, Sopchak L, Boggs A, Comley J (2004) High-throughput screening: searching for higher productivity. J Biomol Screen 9: 354-358.
24. Makara GM, Athanasopoulos J (2005) Improving success rates for lead generation using affinity binding technologies. Curr Opin Biotechnol 16: 666-673.
25. Shelat AA, Guy RK (2007) Scaffold composition and biological relevance of screening libraries. Nat Chem Biol 3: 442-446.
26. Hertzberg RP, Pope AJ (2000) High-throughput screening: new technology for the 21st century. Curr Opin Chem Biol 4: 445-451.
27. Zheng W, Spencer RH, Kiss L (2004) High throughput assay technologies for ion channel drug discovery. Assay Drug Dev Technol 2: 543-552.
28. Kelemen K, Kiesecker C, Zitron E, Bauer A, Scholz E, et al. (2007) Green tea flavonoid epigallocatechin-3-gallate (EGCG) inhibits cardiac hERG potassium channels. Biochem Biophys Res Commun 364: 429-435.
29. Scholz EP, Zitron E, Kiesecker C, Luck S, Thomas D, et al. (2005) Inhibition of cardiac HERG channels by grapefruit flavonoid naringenin: implications for the influence of dietary compounds on cardiac repolarisation. Naunyn Schmiede-bergs Arch Pharmacol 371: 516-525.
30. Scholz EP, Zitron E, Kiesecker C, Thomas D, Kathofer S, et al. (2007) Orange flavonoid hesperetin modulates cardiac hERG potassium channel via binding to amino acid F656. Nutr Metab Cardiovasc Dis 17: 666-675.
31. Zitron E, Scholz E, Owen RW, Luck S, Kiesecker C, et al. (2005) QTc prolongation by grapefruit juice and its potential pharmacological basis: HERG channel blockade by flavonoids. Circulation 111: 835-838.
32. Rozario AO, Turbendian HK, Fogle KJ, Olivier NB, Tibbs GR (2009) Voltage-dependent opening of HCN channels: Facilitation or inhibition by the phytoestrogen, genistein, is determined by the activation status of the cyclic nucleotide gating ring. Biochim Biophys Acta 1788: 1939-1949.
33. Gessner G, Heller R, Hoshi T, Heinemann SH (2007) The amiodarone derivative 2-methyl-3-(3,5-diiodo-4-carboxymethoxybenzyl)benzofuran (KB130015) opens large-conductance Ca2+-activated K+ channels and relaxes vascular smooth muscle. Eur J Pharmacol 555: 185-193.
34. Kamiya K, Nishiyama A, Yasui K, Hojo M, Sanguinetti MC, et al. (2001) Short-and long-term effects of amiodarone on the two components of cardiac delayed rectifier K(+) current. Circulation 103: 1317-1324.
35. Spector PS, Curran ME, Keating MT, Sanguinetti MC (1996) Class III antiarrhythmic drugs block HERG, a human cardiac delayed rectifier K+ channel. Open-channel block by methanesulfonanilides. Circ Res 78: 499-503.
36. Kawasaki K, Masubuchi M, Morikami K, Sogabe S, Aoyama T, et al. (2003) Design and synthesis of novel benzofurans as a new class of antifungal agents targeting fungal N-myristoyltransferase. Part 3. Bioorg Med Chem Lett 13: 87-91.
37. Kema IP, de Vries EG, Muskiet FA (2000) Clinical chemistry of serotonin and metabolites. J Chromatogr B Biomed Sci Appl 747: 33-48.
38. Middleton E, Jr., Kandaswami C, Theoharides TC (2000) The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer. Pharmacol Rev 52: 673-751.
39. Zagotta WN, Hoshi T, Aldrich RW (1989) Gating of single Shaker potassium channels in Drosophila muscle and in Xenopus oocytes injected with Shaker mRNA. Proc Natl Acad Sci U S A 86: 7243-7247.
40. Hamill OP, Marty A, Neher E, Sakmann B, Sigworth FJ (1981) Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflugers Arch 391: 85-100.
41. Chen GQ, Gouaux E (1997) Reduction of membrane protein hydrophobicity by site-directed mutagenesis: introduction of multiple polar residues in helix D of bacteriorhodopsin. Protein Eng 10: 1061-1066.
42. Zagotta WN, Olivier NB, Black KD, Young EC, Olson R, et al. (2003) Structural basis for modulation and agonist specificity of HCN pacemaker channels. Nature 425: 200-205.